LTRN
USDLantern Pharma Inc. Common Stock
即時價格
價格圖表
關鍵指標
市場指標
開盤
$3.260
最高
$3.510
最低
$3.020
交易量
0.09M
公司基本面
市值
36.9M
行業
生物科技
國家
United States
交易統計
平均交易量
0.13M
交易所
NCM
貨幣
USD
52週範圍
相關新聞
Lantern Pharma to Present AI-Driven Cancer Drug Development & Research Platforms at Inaugural AI for Biology and Medicine Symposium at UNT
Lantern showcases two commercially ready, machine learning platforms that have the potential to accelerate drug discovery from months to days and dramatically reduce costs. predictBBB.ai and LBx-AI, will both be
Lantern Pharma Presents LP-284 Clinical Data at 25th LL&M Congress, Highlighting Complete Response in Therapeutically Exhausted DLBCL Patient & Therapeutic Potential in Advanced B-Cell Cancers.
AI-advanced drug candidate achieves complete metabolic response after two cycles in patient who failed CAR-T and bispecific antibody therapies, validating LP-284's mechanism of action. A novel differentiated
Lantern Pharma to Present at the ThinkEquity Conference in NYC on October 30, 2025
Lantern Pharma Inc. (NASDAQ:LTRN), an artificial intelligence (AI) company dedicated to developing cancer therapies and transforming the cost, pace, and timeline of oncology drug discovery and development, today
相關股票
保持更新
設定價格提醒，獲取AI分析更新和即時市場新聞。